Home
McGuireWoods LLP
Royce B. DuBiner
Royce B. DuBiner
McGuireWoods LLP
FDA Releases Final Quality Management System Regulation Amendments
19 Feb 2024 | United States
Off-Label "Free Speech" Theory Does Not Fly For Convicted Former Medical Device Executives In 1st Circuit
25 Jan 2024 | United States
FDA Releases Its Scientific Support For Rescheduling Marijuana To Schedule III
24 Jan 2024 | United States
Drug Enforcement Administration Signals Intent To Reschedule Marijuana
15 Jan 2024 | United States
FDA Provides New Resource On Redundancy Risk Management Plans For Critical Food Manufacturers
04 Jan 2024 | United States
FDA Issues Draft Guidance On Providing Health Care Providers With Scientific Information On Unapproved Uses Of Approved/Cleared Medical Products
03 Jan 2024 | United States
FDA Warning Letter Declares Delta-8 And CBD Gummies 'Adulterated Foods'
19 Dec 2023 | United States
HHS Rescheduling, SAFER Banking Act May Change The Marijuana Landscape
21 Nov 2023 | United States
FDA Proposes Brominated Vegetable Oil Ban
09 Nov 2023 | United States
Oregon Merger Review, New California Law May Signal Increased Scrutiny For Pharmacy Transactions
31 Oct 2023 | United States
California Bans Four Common Food Additives And 26 Chemicals Used In Cosmetics
19 Oct 2023 | United States
FDA Publishes New Guidance On Cybersecurity In Medical Devices
03 Oct 2023 | United States
FDA Issues Draft Guidance For Cosmetic Product Listing And Facility Registration
25 Aug 2023 | United States
Contract Research Organization (CRO) Acquisitions: Critical Due Diligence Pathways
08 Aug 2023 | United States
Breaking The Stigma And Reaping The Medical Benefits: Decriminalizing Psilocybin
04 Jul 2023 | United States
Episode 7 – Oregon Psilocybin Services Act, Measure 109 (Video)
14 Jun 2021 | United States
New Laws And The 2021 Cannabis Effect On Employers
10 May 2021 | United States
Contact Details
Chicago
Chicago
United States

  © Mondaq® Ltd 1994 - 2024. All Rights Reserved.